Antimicrobial susceptibility and β-lactamase production of Moraxella catarrhalis isolates in Taiwan

C. P. Fung, T. N. Jang, C. Y. Liu, Y. J. Lau, Y. C. Liu, Y. C. Chuang, N. Lee

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Between 1 August 1993 and 31 July 1994, 135 clinical isolates of Moraxella catarrhalis were collected from 12 large medical laboratories in Taiwan. The majority of specimens came from sputum (124 isolates). Other specimens included four isolates from throats, three isolates from wounds or pus, two isolates from eyes, one isolate from blood and one from cerebrospinal fluid. Epidemiologically, M. catarrhalis isolates were found frequently in winter and spring with a peak in February, and only sporadically from April to September. The overall rate of β-lactamase producing isolates was 98.5% (132/135). All isolates were considered to be ampicillin-resistant, none were found to be resistant to other β-lactam agents. Among other antimicrobial agents, all isolates were susceptible to chloramphenicol, erythromycin, roxithromycin, ofloxacin and ciprofloxacin, but uniformly resistant to trimethoprim (minimum inhibitory concentration (MIC) ≥ 4 μg/mL, zone diameter ≤ 19 mm). There were 12 isolates (8.8%) resistant to sulfamethoxazole (MIC ≥ 32 μg/mL, zone diameter ≤ 19 mm) and 19 isolates (14.4%) resistant to tetracycline (MIC ≥ 16 μg/mL, zone diameter ≤ 19 mm). The high level of resistance to ampicillin due to β-lactamase production indicates that this is no longer a reliable agent for the treatment of M. catarrhalis infections. Among the β-lactam agents tested, amoxicillin + clavulanate and the cephalosporins were active. These agents appear to be reliable first-line therapies when infection with M. catarrhalis is suspected. Misidentification of the species and difficulties in determining susceptibility to ampicillin are still widespread in Taiwanese laboratories. The application of the butyrate hydrolysis test and an appropriate test for β-lactamase production is necessary for the resolution of these problems.

Original languageEnglish
Pages (from-to)548-554
Number of pages7
JournalJournal of the Formosan Medical Association = Taiwan yi zhi
Volume94
Issue number9
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Moraxella (Branhamella) catarrhalis
Microbial Sensitivity Tests
Taiwan
Lactams
Ampicillin
Roxithromycin
Ampicillin Resistance
Sulfamethoxazole
Clavulanic Acid
Trimethoprim
Ofloxacin
Suppuration
Butyrates
Amoxicillin
Chloramphenicol
Erythromycin
Cephalosporins
Ciprofloxacin
Pharynx
Anti-Infective Agents

Keywords

  • β-lactamase
  • antimicrobial susceptibility
  • Moraxella catarrhalis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Antimicrobial susceptibility and β-lactamase production of Moraxella catarrhalis isolates in Taiwan. / Fung, C. P.; Jang, T. N.; Liu, C. Y.; Lau, Y. J.; Liu, Y. C.; Chuang, Y. C.; Lee, N.

In: Journal of the Formosan Medical Association = Taiwan yi zhi, Vol. 94, No. 9, 1995, p. 548-554.

Research output: Contribution to journalArticle

Fung, C. P. ; Jang, T. N. ; Liu, C. Y. ; Lau, Y. J. ; Liu, Y. C. ; Chuang, Y. C. ; Lee, N. / Antimicrobial susceptibility and β-lactamase production of Moraxella catarrhalis isolates in Taiwan. In: Journal of the Formosan Medical Association = Taiwan yi zhi. 1995 ; Vol. 94, No. 9. pp. 548-554.
@article{2bf978f84ac34ebe8a3d444d8a4434f0,
title = "Antimicrobial susceptibility and β-lactamase production of Moraxella catarrhalis isolates in Taiwan",
abstract = "Between 1 August 1993 and 31 July 1994, 135 clinical isolates of Moraxella catarrhalis were collected from 12 large medical laboratories in Taiwan. The majority of specimens came from sputum (124 isolates). Other specimens included four isolates from throats, three isolates from wounds or pus, two isolates from eyes, one isolate from blood and one from cerebrospinal fluid. Epidemiologically, M. catarrhalis isolates were found frequently in winter and spring with a peak in February, and only sporadically from April to September. The overall rate of β-lactamase producing isolates was 98.5{\%} (132/135). All isolates were considered to be ampicillin-resistant, none were found to be resistant to other β-lactam agents. Among other antimicrobial agents, all isolates were susceptible to chloramphenicol, erythromycin, roxithromycin, ofloxacin and ciprofloxacin, but uniformly resistant to trimethoprim (minimum inhibitory concentration (MIC) ≥ 4 μg/mL, zone diameter ≤ 19 mm). There were 12 isolates (8.8{\%}) resistant to sulfamethoxazole (MIC ≥ 32 μg/mL, zone diameter ≤ 19 mm) and 19 isolates (14.4{\%}) resistant to tetracycline (MIC ≥ 16 μg/mL, zone diameter ≤ 19 mm). The high level of resistance to ampicillin due to β-lactamase production indicates that this is no longer a reliable agent for the treatment of M. catarrhalis infections. Among the β-lactam agents tested, amoxicillin + clavulanate and the cephalosporins were active. These agents appear to be reliable first-line therapies when infection with M. catarrhalis is suspected. Misidentification of the species and difficulties in determining susceptibility to ampicillin are still widespread in Taiwanese laboratories. The application of the butyrate hydrolysis test and an appropriate test for β-lactamase production is necessary for the resolution of these problems.",
keywords = "β-lactamase, antimicrobial susceptibility, Moraxella catarrhalis",
author = "Fung, {C. P.} and Jang, {T. N.} and Liu, {C. Y.} and Lau, {Y. J.} and Liu, {Y. C.} and Chuang, {Y. C.} and N. Lee",
year = "1995",
language = "English",
volume = "94",
pages = "548--554",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "9",

}

TY - JOUR

T1 - Antimicrobial susceptibility and β-lactamase production of Moraxella catarrhalis isolates in Taiwan

AU - Fung, C. P.

AU - Jang, T. N.

AU - Liu, C. Y.

AU - Lau, Y. J.

AU - Liu, Y. C.

AU - Chuang, Y. C.

AU - Lee, N.

PY - 1995

Y1 - 1995

N2 - Between 1 August 1993 and 31 July 1994, 135 clinical isolates of Moraxella catarrhalis were collected from 12 large medical laboratories in Taiwan. The majority of specimens came from sputum (124 isolates). Other specimens included four isolates from throats, three isolates from wounds or pus, two isolates from eyes, one isolate from blood and one from cerebrospinal fluid. Epidemiologically, M. catarrhalis isolates were found frequently in winter and spring with a peak in February, and only sporadically from April to September. The overall rate of β-lactamase producing isolates was 98.5% (132/135). All isolates were considered to be ampicillin-resistant, none were found to be resistant to other β-lactam agents. Among other antimicrobial agents, all isolates were susceptible to chloramphenicol, erythromycin, roxithromycin, ofloxacin and ciprofloxacin, but uniformly resistant to trimethoprim (minimum inhibitory concentration (MIC) ≥ 4 μg/mL, zone diameter ≤ 19 mm). There were 12 isolates (8.8%) resistant to sulfamethoxazole (MIC ≥ 32 μg/mL, zone diameter ≤ 19 mm) and 19 isolates (14.4%) resistant to tetracycline (MIC ≥ 16 μg/mL, zone diameter ≤ 19 mm). The high level of resistance to ampicillin due to β-lactamase production indicates that this is no longer a reliable agent for the treatment of M. catarrhalis infections. Among the β-lactam agents tested, amoxicillin + clavulanate and the cephalosporins were active. These agents appear to be reliable first-line therapies when infection with M. catarrhalis is suspected. Misidentification of the species and difficulties in determining susceptibility to ampicillin are still widespread in Taiwanese laboratories. The application of the butyrate hydrolysis test and an appropriate test for β-lactamase production is necessary for the resolution of these problems.

AB - Between 1 August 1993 and 31 July 1994, 135 clinical isolates of Moraxella catarrhalis were collected from 12 large medical laboratories in Taiwan. The majority of specimens came from sputum (124 isolates). Other specimens included four isolates from throats, three isolates from wounds or pus, two isolates from eyes, one isolate from blood and one from cerebrospinal fluid. Epidemiologically, M. catarrhalis isolates were found frequently in winter and spring with a peak in February, and only sporadically from April to September. The overall rate of β-lactamase producing isolates was 98.5% (132/135). All isolates were considered to be ampicillin-resistant, none were found to be resistant to other β-lactam agents. Among other antimicrobial agents, all isolates were susceptible to chloramphenicol, erythromycin, roxithromycin, ofloxacin and ciprofloxacin, but uniformly resistant to trimethoprim (minimum inhibitory concentration (MIC) ≥ 4 μg/mL, zone diameter ≤ 19 mm). There were 12 isolates (8.8%) resistant to sulfamethoxazole (MIC ≥ 32 μg/mL, zone diameter ≤ 19 mm) and 19 isolates (14.4%) resistant to tetracycline (MIC ≥ 16 μg/mL, zone diameter ≤ 19 mm). The high level of resistance to ampicillin due to β-lactamase production indicates that this is no longer a reliable agent for the treatment of M. catarrhalis infections. Among the β-lactam agents tested, amoxicillin + clavulanate and the cephalosporins were active. These agents appear to be reliable first-line therapies when infection with M. catarrhalis is suspected. Misidentification of the species and difficulties in determining susceptibility to ampicillin are still widespread in Taiwanese laboratories. The application of the butyrate hydrolysis test and an appropriate test for β-lactamase production is necessary for the resolution of these problems.

KW - β-lactamase

KW - antimicrobial susceptibility

KW - Moraxella catarrhalis

UR - http://www.scopus.com/inward/record.url?scp=0028789553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028789553&partnerID=8YFLogxK

M3 - Article

VL - 94

SP - 548

EP - 554

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 9

ER -